Leonid Timashev
Stock Analyst at RBC Capital
(0)
# 4686
Out of 5,337 analysts
77
Total ratings
24.64%
Success rate
-18.81%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BHVN Biohaven | Maintains: Outperform | 61 54 | 19.66 | 174.67% | 11 | May 13, 2025 | |
CYTK Cytokinetics | Maintains: Outperform | 82 80 | 29.99 | 166.76% | 3 | May 7, 2025 | |
ALKS Alkermes | Maintains: Sector Perform | 39 40 | 30.62 | 30.63% | 2 | May 2, 2025 | |
AXSM Axsome Therapeutics | Maintains: Outperform | 190 193 | 103.91 | 85.74% | 9 | Apr 29, 2025 | |
EWTX Edgewise Therapeutic... | Maintains: Outperform | 56 52 | 14.56 | 257.14% | 11 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 8 8 | 1.06 | 654.72% | 6 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 100 100 | 65.66 | 52.3% | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 3 3 | 1.84 | 63.04% | 1 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 40 40 | 18.8 | 112.77% | 6 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Sector Perform | 70 70 | 61.16 | 14.45% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 18 18 | 3.88 | 363.92% | 4 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 86 86 | 27.88 | 208.46% | 12 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Sector Perform | 4 4 | 3.23 | 23.84% | 8 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sector Perform | 240 20 | n/a | n/a | 1 | Oct 18, 2022 |